Salla disease
- 1 January 1983
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 33 (1) , 57
- https://doi.org/10.1212/wnl.33.1.57
Abstract
Salla disease is a lysosomal storage disorder associated with increased urinary excretion of free sialic acid. The main clinical features in 34 patients were severe psychomotor retardation of early onset, ataxia, athetosis, rigidity, spasticity, and impaired speech. Growth retardation, thick calvarium, and exotropia were present in about half the patients. The amplitude of EEG decreased progressively with increasing age. Life span appears to be normal; the age range of the patients was 3 to 63 years. Genealogic studies suggest an autosomal mode of inheritance. A thin-layer method is described for the detection of increased urinary free sialic acid excretion. The basic defect is so far unknown.This publication has 8 references indexed in Scilit:
- Generalized N‐Acetylneuraminic Acid Storage Disease: Quantitation and Identification of the Monosaccharide Accumulating in Brain and Other TissuesJournal of Neurochemistry, 1982
- THE CLINICAL COURSE OF MANNOSIDOSIS1982
- Characterization of Storage Material in Cultured Fibroblasts by Specific Lectin Binding in Lysosomal Storage DiseasesPediatric Research, 1980
- Increased Urinary Excretion of Free N‐Acetylneuraminic Acid in Thirteen Patients with Salla DiseaseEuropean Journal of Biochemistry, 1979
- Separation of glycoprotein-derived oligosaccharides by thin-layer chromatographyAnalytical Biochemistry, 1979
- 'Salla Disease'Archives of Neurology, 1979
- INFANTILE SIALIDOSIS - PHENOCOPY OF TYPE-1 GM1 GANGLIOSIDOSIS DISTINGUISHED BY GENETIC COMPLEMENTATION AND URINARY OLIGOSACCHARIDES1979
- FUCOSIDOSIS TYPE-21976